サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1451790

生殖遺伝市場レポート：製品タイプ、施術タイプ、技術、用途、地域別、2024-2032

Reproductive Genetics Market Report by Product Type, Procedure Type, Technology, Application, and Region 2024-2032
出版日: | 発行: IMARC | ページ情報: 英文 146 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
生殖遺伝市場レポート：製品タイプ、施術タイプ、技術、用途、地域別、2024-2032
出版日: 2024年03月02日
発行: IMARC
ページ情報: 英文 146 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の生殖遺伝市場規模は2023年に57億米ドルに達しました。今後、IMARC Groupは、2024年から2032年にかけて26.5％の成長率（CAGR）を示し、2032年までに501億米ドルに達すると予測しています。大衆の間で遺伝性疾患に対する認識と理解が高まっていること、予防ヘルスケアの導入が進んでいること、生殖補助医療技術（ART）の普及につながる出生率の上昇が市場を牽引する主な要因のいくつかです。

生殖遺伝とは、遺伝情報とそれが生殖の健康と結果に及ぼす影響の研究に焦点を当てた遺伝学の一分野を指します。不妊、妊娠、親から子への遺伝性疾患の伝播に関連する遺伝的要因の分析と理解が含まれます。生殖遺伝は、生殖過程における遺伝的状態の同定と管理を目的とした様々な技術や技法を包含しています。特定の遺伝子変異や保因者の有無について個人やカップルをスクリーニングし、遺伝性疾患を子供に伝えるリスクを評価します。体外受精（IVF）のような生殖補助医療技術では、PGDは子宮に着床する前に胚の遺伝子異常を分析し、特定の遺伝子疾患を持たない胚を選択するのに役立ちます。生殖遺伝は、個人やカップルの保因状態や特定の遺伝子変異の存在を特定することで、遺伝子疾患が子孫に遺伝するリスクを評価するのに役立ちます。

生殖遺伝市場の動向：

世界市場の主な原動力は、大衆の間で遺伝性疾患に対する認識と理解が高まっていることです。また、予防ヘルスケアの普及に伴い、将来の子供の遺伝性疾患のリスクを理解するために遺伝子検査を受ける親候補が増加していることも、市場を活性化させています。出生率の上昇に伴い、体外受精（IVF）や代理出産などの生殖補助医療（ART）の利用が増加しており、市場の見通しは明るいです。これに伴い、次世代シーケンシング（NGS）や高解像度マイクロアレイなどの高度な遺伝子検査技術の継続的な技術開発が市場を刺激しています。さらに、女性の染色体異常の感受性が高くなる結果、母親の年齢が上昇していることも市場に弾みをつけています。これに加えて、数カ国の政府が遺伝子研究や検査を支援する動きを強めており、市場の成長を後押ししています。さらに、ゲノムシークエンシング法の価格が上昇し、大衆がよりアクセスしやすくなっていることも市場を牽引しています。市場に寄与するその他の要因としては、特に新興諸国における所得水準の上昇、消費者に直接遺伝子検査を提供する組織の急増、個別化医療における継続的な技術革新、広範な研究開発（R&D）活動などが挙げられます。

本レポートで扱う主な質問

  • 世界の生殖遺伝市場はこれまでどのように推移してきたか？
  • 世界の生殖遺伝市場における促進要因、市場抑制要因、機会は何か？
  • それぞれの促進要因、抑制要因、機会が世界の生殖遺伝市場に与える影響は？
  • 主要な地域市場は？
  • 最も魅力的な生殖遺伝市場はどの国か？
  • 製品タイプ別の市場内訳は？
  • 生殖遺伝市場で最も魅力的な製品タイプは？
  • 施術タイプ別の市場内訳は？
  • 生殖遺伝市場において最も魅力的な手技タイプは？
  • 技術別の市場内訳は？
  • 生殖遺伝市場において最も魅力的な技術はどれか？
  • 用途別の市場内訳は？
  • 生殖遺伝市場で最も魅力的な用途はどれか？
  • 世界の生殖遺伝市場の競争構造は？
  • 世界の生殖遺伝市場における主要プレイヤー／企業は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界の生殖遺伝市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：製品タイプ別

  • キット
    • 市場動向
    • 市場予測
  • 臨床検査薬（LDT）
    • 市場動向
    • 市場予測
  • 試薬・消耗品
    • 市場動向
    • 市場予測

第7章 市場内訳：施術タイプ別

  • キャリアスクリーニング
    • 市場動向
    • 市場予測
  • 出生前スクリーニング
    • 市場動向
    • 市場予測
  • 着床前遺伝学的検査
    • 市場動向
    • 市場予測
  • 不妊症遺伝子検査
    • 市場動向
    • 市場予測

第8章 市場内訳：技術別

  • 次世代シーケンサー
    • 市場動向
    • 市場予測
  • ポリメラーゼ連鎖反応
    • 市場動向
    • 市場予測
  • インサイチュハイブリダイゼーション（ISH/FISH）
    • 市場動向
    • 市場予測
  • マイクロアレイ
    • 市場動向
    • 市場予測

第9章 市場内訳：用途別

  • 異数性
    • 市場動向
    • 市場予測
  • 構造的染色体異常
    • 市場動向
    • 市場予測
  • 単一遺伝子異常
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳：地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第11章 促進要因、抑制要因、機会

  • 市場概要
  • 促進要因
  • 抑制要因
  • 機会

第12章 バリューチェーン分析

第13章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第14章 価格分析

第15章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Bangkok Genomics Innovation Public Company Limited
    • Centogene N.V.
    • Fulgent Genetics Inc.
    • Igenomix（Vitrolife Group）
    • Invitae Corporation
    • Laboratory Corporation of America Holdings
    • PerkinElmer Inc.
    • Thermo Fisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Reproductive Genetics Market: Major Drivers and Challenges
  • Figure 2: Global: Reproductive Genetics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Reproductive Genetics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Reproductive Genetics Market: Breakup by Product Type (in %), 2023
  • Figure 5: Global: Reproductive Genetics Market: Breakup by Procedure Type (in %), 2023
  • Figure 6: Global: Reproductive Genetics Market: Breakup by Technology (in %), 2023
  • Figure 7: Global: Reproductive Genetics Market: Breakup by Application (in %), 2023
  • Figure 8: Global: Reproductive Genetics Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Reproductive Genetics (Kits) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Reproductive Genetics (Kits) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Reproductive Genetics (Laboratory Developed Tests (LDT)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Reproductive Genetics (Laboratory Developed Tests (LDT)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Reproductive Genetics (Reagents and Consumables) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Reproductive Genetics (Reagents and Consumables) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Reproductive Genetics (Carrier Screening) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Reproductive Genetics (Carrier Screening) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Reproductive Genetics (Pre-Natal Screening) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Reproductive Genetics (Pre-Natal Screening) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Reproductive Genetics (Pre-Implantation Genetic Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Reproductive Genetics (Pre-Implantation Genetic Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Reproductive Genetics (Infertility Genetic Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Reproductive Genetics (Infertility Genetic Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Reproductive Genetics (Next-Generation Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Reproductive Genetics (Next-Generation Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Reproductive Genetics (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Reproductive Genetics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Reproductive Genetics (In Situ Hybridization (ISH/FISH)) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Reproductive Genetics (In Situ Hybridization (ISH/FISH)) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Reproductive Genetics (Microarray) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Reproductive Genetics (Microarray) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Reproductive Genetics (Aneuploidy) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Reproductive Genetics (Aneuploidy) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Reproductive Genetics (Structural Chromosomal Abnormality) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Reproductive Genetics (Structural Chromosomal Abnormality) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Reproductive Genetics (Single Gene Disorder) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Reproductive Genetics (Single Gene Disorder) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Reproductive Genetics (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Reproductive Genetics (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: North America: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: North America: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: United States: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: United States: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Canada: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Canada: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Asia-Pacific: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Asia-Pacific: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: China: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: China: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: Japan: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: Japan: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: India: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: India: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: South Korea: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: South Korea: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Australia: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Australia: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Indonesia: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Indonesia: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Others: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Others: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Europe: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Europe: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Germany: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Germany: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: France: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: France: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: United Kingdom: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: United Kingdom: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Italy: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Italy: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Spain: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Spain: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Russia: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Russia: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Others: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Others: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Latin America: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Latin America: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Brazil: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Brazil: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Mexico: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Mexico: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Others: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Others: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Middle East and Africa: Reproductive Genetics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Middle East and Africa: Reproductive Genetics Market: Breakup by Country (in %), 2023
  • Figure 87: Middle East and Africa: Reproductive Genetics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 88: Global: Reproductive Genetics Industry: Drivers, Restraints, and Opportunities
  • Figure 89: Global: Reproductive Genetics Industry: Value Chain Analysis
  • Figure 90: Global: Reproductive Genetics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Reproductive Genetics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Reproductive Genetics Market Forecast: Breakup by Product Type (in Million US$), 2024-2032
  • Table 3: Global: Reproductive Genetics Market Forecast: Breakup by Procedure Type (in Million US$), 2024-2032
  • Table 4: Global: Reproductive Genetics Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 5: Global: Reproductive Genetics Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 6: Global: Reproductive Genetics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Reproductive Genetics Market: Competitive Structure
  • Table 8: Global: Reproductive Genetics Market: Key Players
目次
Product Code: SR112024A10134

The global reproductive genetics market size reached US$ 5.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 50.1 Billion by 2032, exhibiting a growth rate (CAGR) of 26.5% during 2024-2032. The growing awareness and understanding of genetic disorders among the masses, the rising adoption of preventive healthcare, and the increasing fertility rates leading to a higher uptake of assisted reproductive technologies (ART) represent some of the key factors driving the market.

Reproductive genetics refers to the branch of genetics that focuses on the study of genetic information and its impact on reproductive health and outcomes. It involves the analysis and understanding of genetic factors related to fertility, pregnancy, and the transmission of genetic disorders from parents to their offspring. Reproductive genetics encompasses various techniques and technologies aimed at identifying and managing genetic conditions during the reproductive process. Screening individuals or couples for specific genetic mutations or carrier status to assess the risk of passing on genetic disorders to their children. In assisted reproductive technologies such as in vitro fertilization (IVF), PGD involves the analysis of embryos for genetic abnormalities before their implantation in the uterus, helping to select embryos without specific genetic disorders. Reproductive genetics helps assess the risk of transmitting genetic disorders to offspring by identifying carrier status or the presence of specific genetic mutations in individuals or couples.

Reproductive Genetics Market Trends:

The global market is primarily driven by the growing awareness and understanding of genetic disorders among the masses. Also, the rising adoption of preventive healthcare leading to a higher number of prospective parents undergoing genetic testing to understand the risks of genetic disorders in their future children is fueling the market. With the increasing fertility rates, there is a higher uptake of assisted reproductive technologies (ART) such as In-Vitro Fertilization (IVF) and surrogacy, which is creating a positive market outlook. In line with this, continual technological developments in advanced genetic testing techniques such as Next-Generation Sequencing (NGS) and high-resolution microarrays are stimulating the market. Moreover, the increasing maternal age resulting in a higher susceptibility of chromosomal abnormalities in women is providing an impetus to the market. In addition to this, governments of several countries are increasingly supporting genetic research and testing, thereby catalyzing the growth of the market. The market is further driven by the rising affordability of genomic sequencing procedures, resulting in higher accessibility among the masses. Some of the other factors contributing to the market include inflating income levels, particularly in developing countries, the proliferation of organizations offering direct-to-consumer genetic tests, continual innovations in personalized medicine, and extensive research and development (R&D) activities.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global reproductive genetics market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on product type, procedure type, technology and application.

Product Type Insights:

Kits

Laboratory Developed Tests (LDT)

Reagents and Consumables

The report has provided a detailed breakup and analysis of the reproductive genetics market based on the product type. This includes kits, laboratory developed tests (LDT), and reagents and consumables. According to the report, kits represented the largest segment.

Procedure Type Insights:

Carrier Screening

Pre-Natal Screening

Pre-Implantation Genetic Testing

Infertility Genetic Testing

A detailed breakup and analysis of the reproductive genetics market based on the procedure type has also been provided in the report. This includes carrier screening, pre-natal screening, pre-implantation genetic testing, and infertility genetic testing. According to the report, carrier screening accounted for the largest market share.

Technology Insights:

Next-Generation Sequencing

Polymerase Chain Reaction

In Situ Hybridization (ISH/FISH)

Microarray

The report has provided a detailed breakup and analysis of the reproductive genetics market based on the technology. This includes next-generation sequencing, polymerase chain reaction, in situ hybridization (ISH/FISH), and microarray. According to the report, next-generation sequencing represented the largest segment.

Application Insights:

Aneuploidy

Structural Chromosomal Abnormality

Single Gene Disorder

Others

A detailed breakup and analysis of the reproductive genetics market based on the application has also been provided in the report. This includes aneuploidy, structural chromosomal abnormality, single gene disorder, and others. According to the report, aneuploidy accounted for the largest market share.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for reproductive genetics. Some of the factors driving the North America reproductive genetics market included its continual technological advancements in the field of genetics, the rising adoption of preventive healthcare high healthcare expenditure, etc.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global reproductive genetics market. Detailed profiles of all major companies have been provided. Some of the companies covered include Bangkok Genomics Innovation Public Company Limited, Centogene N.V., Fulgent Genetics Inc., Igenomix (Vitrolife Group), Invitae Corporation, Laboratory Corporation of America Holdings, PerkinElmer Inc., Thermo Fisher Scientific Inc., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global reproductive genetics market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global reproductive genetics market?
  • What is the impact of each driver, restraint, and opportunity on the global reproductive genetics market?
  • What are the key regional markets?
  • Which countries represent the most attractive reproductive genetics market?
  • What is the breakup of the market based on the product type?
  • Which is the most attractive product type in the reproductive genetics market?
  • What is the breakup of the market based on the procedure type?
  • Which is the most attractive procedure type in the reproductive genetics market?
  • What is the breakup of the market based on the technology?
  • Which is the most attractive technology in the reproductive genetics market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the reproductive genetics market?
  • What is the competitive structure of the global reproductive genetics market?
  • Who are the key players/companies in the global reproductive genetics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Reproductive Genetics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product Type

  • 6.1 Kits
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Laboratory Developed Tests (LDT)
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Reagents and Consumables
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast

7 Market Breakup by Procedure Type

  • 7.1 Carrier Screening
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Pre-Natal Screening
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Pre-Implantation Genetic Testing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Infertility Genetic Testing
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Next-Generation Sequencing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Polymerase Chain Reaction
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 In Situ Hybridization (ISH/FISH)
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Microarray
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Aneuploidy
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Structural Chromosomal Abnormality
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Single Gene Disorder
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 Drivers, Restraints, and Opportunities

  • 11.1 Overview
  • 11.2 Drivers
  • 11.3 Restraints
  • 11.4 Opportunities

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Bangkok Genomics Innovation Public Company Limited
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Centogene N.V.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 Fulgent Genetics Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Igenomix (Vitrolife Group)
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Invitae Corporation
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
    • 15.3.6 Laboratory Corporation of America Holdings
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 PerkinElmer Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Thermo Fisher Scientific Inc.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.